1. Home
  2. GKOS vs RMTI Comparison

GKOS vs RMTI Comparison

Compare GKOS & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • RMTI
  • Stock Information
  • Founded
  • GKOS 1998
  • RMTI 1994
  • Country
  • GKOS United States
  • RMTI United States
  • Employees
  • GKOS N/A
  • RMTI N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • RMTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • GKOS Health Care
  • RMTI Health Care
  • Exchange
  • GKOS Nasdaq
  • RMTI Nasdaq
  • Market Cap
  • GKOS 5.1B
  • RMTI 34.9M
  • IPO Year
  • GKOS 2015
  • RMTI 1998
  • Fundamental
  • Price
  • GKOS $90.36
  • RMTI $1.15
  • Analyst Decision
  • GKOS Strong Buy
  • RMTI Strong Buy
  • Analyst Count
  • GKOS 13
  • RMTI 2
  • Target Price
  • GKOS $135.15
  • RMTI $4.00
  • AVG Volume (30 Days)
  • GKOS 1.1M
  • RMTI 194.8K
  • Earning Date
  • GKOS 04-30-2025
  • RMTI 05-12-2025
  • Dividend Yield
  • GKOS N/A
  • RMTI N/A
  • EPS Growth
  • GKOS N/A
  • RMTI N/A
  • EPS
  • GKOS N/A
  • RMTI N/A
  • Revenue
  • GKOS $404,523,000.00
  • RMTI $101,489,000.00
  • Revenue This Year
  • GKOS $27.84
  • RMTI N/A
  • Revenue Next Year
  • GKOS $27.88
  • RMTI $10.42
  • P/E Ratio
  • GKOS N/A
  • RMTI N/A
  • Revenue Growth
  • GKOS 23.92
  • RMTI 21.38
  • 52 Week Low
  • GKOS $77.10
  • RMTI $0.86
  • 52 Week High
  • GKOS $163.71
  • RMTI $5.15
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 47.66
  • RMTI 49.12
  • Support Level
  • GKOS $84.26
  • RMTI $1.08
  • Resistance Level
  • GKOS $92.27
  • RMTI $1.21
  • Average True Range (ATR)
  • GKOS 3.86
  • RMTI 0.07
  • MACD
  • GKOS 0.66
  • RMTI 0.02
  • Stochastic Oscillator
  • GKOS 65.16
  • RMTI 48.33

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About RMTI Rockwell Medical Inc.

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.

Share on Social Networks: